255 related articles for article (PubMed ID: 23542158)
21. Relationship between the intensity of heparin anticoagulation and clinical outcomes in patients receiving glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction.
Rozenman Y; Mehran R; Witzenbichler B; Dangas G; Desaga M; Kochman J; Nilsen DW; Finkelstein A; Mosseri M; Stone GW
Catheter Cardiovasc Interv; 2013 Jan; 81(1):E9-14. PubMed ID: 22511592
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Buyukkaya E; Poyraz F; Karakas MF; Kurt M; Akcay AB; Akpinar I; Motor S; Turak O; Ozturk OH; Sen N; Akpek M; Kaya MG; Gibson CM
Am J Cardiol; 2013 Jul; 112(2):187-93. PubMed ID: 23601576
[TBL] [Abstract][Full Text] [Related]
23. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
[TBL] [Abstract][Full Text] [Related]
24. Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
Akgul O; Baycan OF; Bulut U; Somuncu MU; Pusuroglu H; Ozyilmaz S; Gul M; Demir AR; Yılmaz E; Yazan S; Kokturk U; Cetin I; Uyarel H
Coron Artery Dis; 2015 Nov; 26(7):592-7. PubMed ID: 26061437
[TBL] [Abstract][Full Text] [Related]
25. CRUSADE bleeding risk score validation for ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Ariza-Solé A; Sánchez-Elvira G; Sánchez-Salado JC; Lorente-Tordera V; Salazar-Mendiguchía J; Sánchez-Prieto R; Romaguera-Torres R; Ferreiro-Gutiérrez JL; Gómez-Hospital JA; Cequier-Fillat A
Thromb Res; 2013; 132(6):652-8. PubMed ID: 24112751
[TBL] [Abstract][Full Text] [Related]
26. Admission hyperglycemia predicts inhospital mortality and major adverse cardiac events after primary percutaneous coronary intervention in patients without diabetes mellitus.
Ekmekci A; Cicek G; Uluganyan M; Gungor B; Osman F; Ozcan KS; Bozbay M; Ertas G; Zencirci A; Sayar N; Eren M
Angiology; 2014 Feb; 65(2):154-9. PubMed ID: 23657174
[TBL] [Abstract][Full Text] [Related]
27. Elevated admission serum creatinine predicts poor myocardial blood flow and one-year mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
Zhao L; Wang L; Zhang Y
J Invasive Cardiol; 2009 Oct; 21(10):493-8. PubMed ID: 19805833
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of red blood cell transfusion in patients undergoing primary angioplasty for ST elevation myocardial infarction.
Ergelen M; Uyarel H; Altay S; Ayhan E; Isik T; Bacaksiz A; Kemaloğlu T; Gül M; Cicek G; Kul S; Ertas G; Tasal A
Coron Artery Dis; 2012 Dec; 23(8):517-22. PubMed ID: 23013926
[TBL] [Abstract][Full Text] [Related]
29. Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry).
Cavender MA; Milford-Beland S; Roe MT; Peterson ED; Weintraub WS; Rao SV
Am J Cardiol; 2009 Aug; 104(4):507-13. PubMed ID: 19660603
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Factors for In-Hospital and Long-Term Survival in Patients with Acute ST-Segment Elevation Myocardial Infarction after Percutaneous Coronary Intervention.
Hou LL; Gao C; Feng J; Chen ZF; Zhang J; Jiang YJ; Li XX; Wang BN
Tohoku J Exp Med; 2017 May; 242(1):27-35. PubMed ID: 28496014
[TBL] [Abstract][Full Text] [Related]
31. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).
Cox DA; Stone GW; Grines CL; Stuckey T; Zimetbaum PJ; Tcheng JE; Turco M; Garcia E; Guagliumi G; Iwaoka RS; Mehran R; O'Neill WW; Lansky AJ; Griffin JJ;
Am J Cardiol; 2006 Aug; 98(3):331-7. PubMed ID: 16860018
[TBL] [Abstract][Full Text] [Related]
32. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
Pres D; Gasior M; Strojek K; Gierlotka M; Hawranek M; Lekston A; Wilczek K; Tajstra M; Gumprecht J; Poloński L
Kardiol Pol; 2010 Jul; 68(7):743-51. PubMed ID: 20648428
[TBL] [Abstract][Full Text] [Related]
33. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
34. Direct ambulance transport to catheterization laboratory reduces door-to-balloon time in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the DIRECT-STEMI study.
Qiu JP; Zhang Q; Lu JD; Wang HR; Lin J; Ge ZR; Zhang RY; Shen WF
Chin Med J (Engl); 2011 Mar; 124(6):805-10. PubMed ID: 21518584
[TBL] [Abstract][Full Text] [Related]
35. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of very low admission LDL-cholesterol levels in ST-segment elevation myocardial infarction compared in statin-pretreated and statin-naive patients undergoing primary percutaneous coronary intervention.
Oduncu V; Erkol A; Kurt M; Tanboğa IH; Karabay CY; Şengül C; Bulut M; Özveren O; Fotbolcu H; Akgün T; Türkyilmaz E; Kırma C
Int J Cardiol; 2013 Jul; 167(2):458-63. PubMed ID: 22305817
[TBL] [Abstract][Full Text] [Related]
37. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
[TBL] [Abstract][Full Text] [Related]
38. The significance of anaemia in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Bolińska S; Sobkowicz B; Zaniewska J; Chlebińska I; Boliński J; Milewski R; Tycińska A; Musiał W
Kardiol Pol; 2011; 69(1):33-9. PubMed ID: 21267962
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy and outcome of primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction due to saphenous vein graft occlusion].
Ergelen M; Uyarel H; Gül M; Türer A; Yıldırım E; Bozbay M; Demirci D; Ersan D; Türkkan C; Uluganyan M; Tezel T
Turk Kardiyol Dern Ars; 2010 Dec; 38(8):531-6. PubMed ID: 21248452
[TBL] [Abstract][Full Text] [Related]
40. Patients with anemia on admission who have undergone primary angioplasty for ST elevation myocardial infarction: in-hospital and long-term clinical outcomes.
Ayhan E; Aycicek F; Uyarel H; Ergelen M; Cicek G; Gul M; Osmonov D; Yildirim E; Bozbay M; Ugur M; Işik T; Tezel T
Coron Artery Dis; 2011; 22(6):375-9. PubMed ID: 21558854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
